6 months treatment with a single antiplatelet agent

DRUG2 trials

Sponsors

National Institute of Cardiology, Warsaw, Poland

Conditions

Atrial Fibrillation

Phase 4

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure

RecruitingNCT03445949

National Institute of Cardiology, Warsaw, PolandAtrial Fibrillation

Start: 2018-01-23End: 2027-06-23Target: 200Updated: 2023-07-11

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients

RecruitingNCT05660811

National Institute of Cardiology, Warsaw, PolandAtrial Fibrillation

Start: 2022-09-28End: 2026-06-30Target: 80Updated: 2024-06-25